- CEO
- Quan Zhong Lin
- Full Time Employees
- 116
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- Hongxing Intl. Business Bldg 2 Chengdu SI People's Republic of China 610021
- IPO Date
- Feb 29, 2008
- Business
- AiXin Life International, Inc. (AIXN) is a holding company primarily engaged in the development, manufacture, marketing, and sale of healthcare products, nutritional supplements, and wellness items in the People's Republic of China. The company operates through four main segments—Products, Pharmacies, Hotel, and Manufacture and Sales—offering a range of items including herbs, greens, and traditional Chinese remedies; functional products such as weight management tools, probiotics, foods, and drinks; and specific branded formulations like rhino king, colostrum powder derived from goat's milk, tong li ke, gammaoling granules, amoxicillin capsules, loratadine tablets, and fuyang granules, which it sells via company-owned offices, pharmacies, direct marketing, e-commerce, exhibitions, conferences, and person-to-person channels. Through its subsidiary AiXinZhonghong and affiliates like AiXin Tang chain pharmacies and Sheng Shang Yan Hotel, it also provides pharmacy retail services featuring pharmaceuticals, pre-packaged foods, dietary supplements, dairy, daily necessities, cosmetics, electronics, and disinfectants, alongside hotel operations and marketing-distribution support to third-party healthcare manufacturers. Founded in 1987 and headquartered at Hongxing International Business Building 2, 14th Floor, Chengdu, Sichuan Province, China, the company, formerly Mercari Communications Group Ltd., targets health-conscious consumers in China with recent expansions including the opening of AiXin Tang Wenjiang Gonghe Road pharmacy store in September 2023 and participation in promotional events showcasing products like Run Cang Sheng's Sanqi fresh extract liquid and Sanqi goji olive fresh extract liquid in April 2023, alongside completion of key acquisitions reported with third-quarter 2023 financial results.